Drug Substitution Language In E-Health Record Regs Concerns PhRMA
The Pharmaceutical Research and Manufacturers of America and drug manufacturers offer comments on HHS’ proposed next-stage requirements for electronic health records, which physicians and hospitals will have to meet in order to qualify for incentive payments for the meaningful use of EHRs.
You may also be interested in...
At the Council for Affordable Health Coverage’s event to launch its Prescription for Healthy America campaign, PhRMA President and CEO John Castellani says opening up the ability of drug manufacturers to communicate about their products could help improve medication adherence.
FDA’s vision for electronic health records is being incorporated into a new application launched by PDR Network.
A program to bring about wider adoption of health information technology in physicians' offices is mirroring the conceptual framework of rewarding and penalizing physicians through Medicare payments that was used to promote adoption of electronic prescribing